NCT06795412 2026-03-06
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
Pyxis Oncology, Inc
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT05508334 2025-12-22
A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours
RemeGen Co., Ltd.
Phase 1/2 Completed
NCT05804526 2024-04-30
A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours
RemeGen Co., Ltd.
Phase 1/2 Recruiting
NCT01581060 2014-05-16
Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours
Heidelberg Pharma AG
Phase 1/2 Terminated